Condition

Autoimmune Disease clinical trials and research

• 8Clinical trials
• 3Countries

Newest Autoimmune Disease clinical trials

All recruiting trials (8)

• Subcutaneous GenSci136 given to healthy adults to check safety and body behavior

  This trial tests whether a single or repeated subcutaneous dose of GenSci136 is safe and how it behaves in the body of healthy adults aged 18–45.

  Recruiting Phase 1 Changchun GeneScience Pharmaceutical Co., Ltd. · Shanghai, Shanghai Municipality · NCT07366866

• Remdesivir for RSV in immunocompromised adults

  This trial tests whether a short course of intravenous remdesivir can help adults whose immune systems are weakened by cellular or bispecific antibody therapies recover from upper respiratory RSV infection.

  Recruiting at 3 sites Phase 2 Fred Hutchinson Cancer Center · Duarte, California and 2 other locations · NCT06817889

• Exploring genetic factors in autoimmune and autoinflammatory diseases

  This study is trying to find out how genes affect autoimmune and autoinflammatory diseases, especially VEXAS syndrome, by looking at samples from patients with known or unknown inflammatory conditions.

  Recruiting at 2 sites NYU Langone Health · New York, New York and 1 other locations · NCT06004349

• Educational tool for melanoma patients with autoimmune diseases

  This study is testing a new educational tool to help melanoma patients with autoimmune diseases understand their treatment options better and see how easy it is for them to use.

  Recruiting M.D. Anderson Cancer Center · Houston, Texas · NCT04751396

• Using nivolumab to treat patients with autoimmune disorders and advanced cancer

  This study is testing if nivolumab can safely help people with autoimmune disorders who also have advanced cancer by looking at how well it works and what side effects it might cause.

  Recruiting at 40 sites Phase 1 National Cancer Institute (NCI) · Birmingham, Alabama and 51 other locations · NCT03816345

• Studying how genetic testing can improve medication use in patients

  This study is trying to see if using genetic testing can help doctors choose the right medications for patients with heart diseases, inflammatory bowel diseases, and autoimmune diseases to improve their treatment outcomes.

  Recruiting University of Chicago · Chicago, Illinois · NCT01280825

• Combining Rituximab and Cyclosporine for Membranous Nephropathy

  This study tests if combining two medications, rituximab and cyclosporine, can help people with membranous nephropathy improve their kidney function and reduce protein in their urine.

  Recruiting at 2 sites Phase 2 National Institutes of Health Clinical Center (CC) · Bethesda, Maryland and 1 other locations · NCT00977977

• Understanding the natural history of bronchiectasis

  This study looks at how bronchiectasis develops over time in people with chronic lung infections, especially focusing on genetic and immune factors that might make them more prone to these infections.

  Recruiting National Institutes of Health Clinical Center (CC) · Bethesda, Maryland · NCT00943514

Related topics

Quick answers

How many Autoimmune Disease clinical trials are recruiting right now?

8, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

In 3 countries. The most sites are in United States (7 trials), China (1 trial), Canada (1 trial). Each study page lists its sites and which ones are recruiting.

What phases are they in?

Phase 1: 2, Phase 2: 2. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →